Focus Stocks
Johnson & Johnson to Participate in 2012 Leerink Swann Global Health Care Conference
Published on Thursday, 09 February 2012 13:57 Written by TradersHuddle Staff
NEW BRUNSWICK, N.J., Feb. 9, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 2012 Leerink Swann Global Health Care Conference on Thursday, Feb. 16, at The Waldorf Astoria in New York, N.Y. Sheri McCoy, Vice Chairman of the Executive Committee, will represent the Company in a session scheduled at 9:00 a.m. (Eastern Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast and podcast replay will be available approximately two hours after the live webcast.
SOURCE Johnson & Johnson
Related Articles
- Biosense Webster Announces Launch of the THERMOCOOL® SF NAV Catheter With Curve Visualization
- Biosense Webster Collaborates to Bring Innovative Solutions to Electrophysiologists Around the World
- Leading Authority On Eye Allergies Shares Tips, Offers Advice For Eye Allergy Sufferers On New Edition Of Healthy Vision™ With Dr. Val Jones
- Johnson & Johnson to Participate in 2012 Deutsche Bank Securities, Inc. 37th Annual Health Care Conference
- Johnson & Johnson Holds 2012 Annual Meeting of Shareholders
- Johnson & Johnson Announces Dividend Increase of 7.0%
- Johnson & Johnson to Webcast Annual Meeting of Shareholders
- Market Soars as Earnings Season Begins
- Dow Jones Round Up - Higher: KO, HPQ, CVX
- Johnson & Johnson Reports 2012 First-Quarter Results:
Related Partner Headlines
- Dow Component Johnson & Johnson (JNJ) To Go Ex-dividend Tomorrow - TheStreet.com
- Johnson & Johnson (JNJ): Today's Featured Drugs Loser - TheStreet.com
- Johnson & Johnson Remains Too Big to Succeed - TheStreet.com
- Johnson & Johnson (JNJ): Today's Featured Drugs Loser - TheStreet.com
- Two Pharmaceutical Plays to Consider - TheStreet.com
- Johnson & Johnson Announces Dividend Increase of 7.0% to $0.61 - Benzinga
- Johnson & Johnson (JNJ): Today's Featured Drugs Winner - TheStreet.com
- 3 Cancer-Drug Stocks Look Strong - TheStreet.com
- Johnson & Johnson Profit Beats, Sales Slip 2.4% - TheStreet.com
- Johnson & Johnson Stock Upgraded (JNJ) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Top 4 Small-Cap Stocks In The Heavy Construction Industry With The Lowest PEG Ratio - Benzinga -
Earnings Scheduled For May 25 - Benzinga -
Cramer's 'Mad Money' Recap: Big Government Not Protecting the Little Guys - TheStreet.com -
The Global Retrenchment Accelerates - TheStreet.com -
Bain Capital Sent 0,000-Plus to Obama and Dems in 2008 - TheStreet.com -
Market Preview: Low-Grade Uncertainty - TheStreet.com -
The EPA's Dangerous Game - TheStreet.com -
Sticking with the Preferred Plan - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Syngenta settles atrazine litigation in the USA -
Atrazine Litigation Settled -
USFS, BLM Hire Youth for Public Lands Conservation Jobs -
SCVBank Elects Scott K. Rushing as New Chairman -
Heritage Oaks Bancorp to Pay Trust Preferred Interest and Accumulated TARP Dividends -
Law Office of Brodsky & Smith, LLC Announces Investigation of Ariba, Inc. -
Following Its Record 73% Jump FY 2011 Revenue, Privately-Held Milton Security Group Reports Repeat Double-Digit Sales Growth for First Quarter 2012 -
Diamond Value Management strategy and corporate turnaround leverages Rockwell repositioning









